Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    May 2017
  1. SILVERBERG JI, Simpson EL
    Reply to: "Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis alters interpretation".
    J Am Acad Dermatol. 2017;76:e183-e184.
    PubMed     Text format    


  2. MARGOLIS DJ, Mitra N
    Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis changes interpretation.
    J Am Acad Dermatol. 2017;76:e181.
    PubMed     Text format    


  3. SILVERBERG JI, Simpson EL
    Reply to: "Conclusions about atopic dermatitis persistence might be premature".
    J Am Acad Dermatol. 2017;76:e179.
    PubMed     Text format    


  4. ABUABARA K, Langan SM, Yu AM
    Conclusions about atopic dermatitis persistence might be premature.
    J Am Acad Dermatol. 2017;76:e177-e178.
    PubMed     Text format    


  5. RAMIREZ F, Chren MM, Botto N
    A review of the impact of patch testing on quality of life in allergic contact dermatitis.
    J Am Acad Dermatol. 2017;76:1000-1004.
    PubMed     Text format    


    April 2017
  6. THYSSEN JP, Skov L, Hamann CR, Gislason GH, et al
    Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30123.
    PubMed     Text format     Abstract available


  7. HAMANN CR, Hamann D, Egeberg A, Johansen JD, et al
    Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30152.
    PubMed     Text format     Abstract available


    December 2016
  8. SAUDER MB, McEvoy A, Ramien ML
    Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis.
    J Am Acad Dermatol. 2016;75:1281-1283.
    PubMed     Text format    


  9. VAN DER SCHAFT J, Ariens LF, Bruijnzeel-Koomen CA, de Bruin-Weller MS, et al
    Serum vitamin D status in adult patients with atopic dermatitis: Recommendations for daily practice.
    J Am Acad Dermatol. 2016;75:1257-1259.
    PubMed     Text format    


    November 2016
  10. TOTRI CR, Eichenfield LF, Logan K, Proudfoot L, et al
    Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    J Am Acad Dermatol. 2016 Nov 14. pii: S0190-9622(16)30832.
    PubMed     Text format     Abstract available


  11. FARAHNIK B, Beroukhim K, Danesh M, Nakamura M, et al
    Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study.
    J Am Acad Dermatol. 2016;75:1068-1071.
    PubMed     Text format    


  12. FARAHNIK B, Kwong B, Murase J
    General management strategy for epidermal growth factor receptor inhibitor-associated papulopustular eruption.
    J Am Acad Dermatol. 2016;75:e191.
    PubMed     Text format    


  13. DEZA G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, et al
    Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
    J Am Acad Dermatol. 2016;75:918-924.
    PubMed     Text format     Abstract available


    October 2016
  14. WEISS D, Schaschinger M, Ristl R, Gruber R, et al
    Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.
    J Am Acad Dermatol. 2016 Oct 13. pii: S0190-9622(16)30599.
    PubMed     Text format     Abstract available


  15. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Autoimmune diseases in adults with atopic dermatitis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30734.
    PubMed     Text format     Abstract available


  16. EGEBERG A, Skov L, Andersen YM, Mallbris L, et al
    Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  17. HILL MK, Kheirandish Pishkenari A, Braunberger TL, Armstrong AW, et al
    Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review.
    J Am Acad Dermatol. 2016 Sep 8. pii: S0190-9622(16)30474.
    PubMed     Text format     Abstract available


  18. HAN B, Wu WH, Bae JM, Son SJ, et al
    Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity.
    J Am Acad Dermatol. 2016;75:629-31.
    PubMed     Text format    


  19. GONZALEZ ME, Schaffer JV, Orlow SJ, Gao Z, et al
    Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
    J Am Acad Dermatol. 2016;75:481-493.
    PubMed     Text format     Abstract available


    August 2016
  20. KIM JP, Chao LX, Simpson EL, Silverberg JI, et al
    Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 17. pii: S0190-9622(16)30309.
    PubMed     Text format     Abstract available


  21. KANTOR R, Kim A, Thyssen J, Silverberg JI, et al
    Association of atopic dermatitis with smoking: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 16. pii: S0190-9622(16)30495.
    PubMed     Text format     Abstract available


  22. BARBAROT S, Rogers NK, Abuabara K, Aubert H, et al
    Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
    J Am Acad Dermatol. 2016 Aug 10. pii: S0190-9622(16)30325.
    PubMed     Text format     Abstract available


  23. MINKIS K, Whittington A, Alam M
    Dermatologic surgery emergencies: Complications caused by systemic reactions, high-energy systems, and trauma.
    J Am Acad Dermatol. 2016;75:265-84.
    PubMed     Text format     Abstract available


    July 2016
  24. HANIFIN JM
    New drugs for atopic dermatitis may provide clues to basic mechanisms of itch and inflammation.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30390.
    PubMed     Text format    


  25. PALLER AS, Tom WL, Lebwohl MG, Blumenthal RL, et al
    Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30330.
    PubMed     Text format     Abstract available


  26. WEI EX, Kirsner RS, Eaglstein WH
    End points in dermatologic clinical trials: A review for clinicians.
    J Am Acad Dermatol. 2016;75:203-9.
    PubMed     Text format     Abstract available


    June 2016
  27. KOHLI N, Nedorost S
    Inflamed skin predisposes to sensitization to less potent allergens.
    J Am Acad Dermatol. 2016 Jun 8. pii: S0190-9622(16)01548.
    PubMed     Text format     Abstract available


  28. SIMPSON EL, Gadkari A, Worm M, Soong W, et al
    Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 Jun 4. pii: S0190-9622(16)30193.
    PubMed     Text format     Abstract available


  29. CHEN YC, Rosenblum MD, Shinkai K
    Plasmacytoid dendritic cells (pDCs) and regulatory T (Treg) cells may be the key to viral reactivation in drug-induced hypersensitivity syndrome (DIHS).
    J Am Acad Dermatol. 2016;74:1288-9.
    PubMed     Text format    


  30. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient management and education.
    J Am Acad Dermatol. 2016;74:1043-54.
    PubMed     Text format     Abstract available


  31. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient diagnosis and evaluation.
    J Am Acad Dermatol. 2016;74:1029-40.
    PubMed     Text format     Abstract available


  32. CLARK JJ, Secrest AM, Hull CM, Eliason MJ, et al
    The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
    J Am Acad Dermatol. 2016;74:1274-6.
    PubMed     Text format    


  33. FAIVRE C, Villani AP, Aubin F, Lipsker D, et al
    Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
    J Am Acad Dermatol. 2016;74:1153-9.
    PubMed     Text format     Abstract available


  34. MOON AT, Castelo-Soccio L, Yan AC
    Emergency department utilization of pediatric dermatology (PD) consultations.
    J Am Acad Dermatol. 2016;74:1173-7.
    PubMed     Text format     Abstract available


    May 2016
  35. KOHN LL, Kang Y, Antaya RJ
    A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 May 31. pii: S0190-9622(16)30199.
    PubMed     Text format     Abstract available


  36. HANIFIN JM, Ellis CN, Frieden IJ, Folster-Holst R, et al
    OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.
    J Am Acad Dermatol. 2016 May 14. pii: S0190-9622(16)30025.
    PubMed     Text format     Abstract available


  37. BROEDERS JA, Ahmed Ali U, Fischer G
    Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    J Am Acad Dermatol. 2016 May 11. pii: S0190-9622(16)01495.
    PubMed     Text format     Abstract available


    March 2016
  38. AUBIN F, Avenel-Audran M, Jeanmougin M, Adamski H, et al
    Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    J Am Acad Dermatol. 2016;74:574-5.
    PubMed     Text format    


    February 2016
  39. GILLIAM AE, Madden N, Sendowski M, Mioduszewski M, et al
    Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): A randomized controlled trial.
    J Am Acad Dermatol. 2016;74:375-377.
    PubMed     Text format    


  40. ERRICHETTI E, Pegolo E, Stinco G
    Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.
    J Am Acad Dermatol. 2016;74:e29-31.
    PubMed     Text format    


  41. CURTIS JA, Christensen LC, Paine AR, Collins Brummer G, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    J Am Acad Dermatol. 2016;74:379-80.
    PubMed     Text format    


  42. PASCOE VL, Fenves AZ, Wofford J, Jackson JM, et al
    The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.
    J Am Acad Dermatol. 2016;74:247-70.
    PubMed     Text format     Abstract available


    January 2016
  43. SIMPSON EL, Bieber T, Eckert L, Wu R, et al
    Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
    J Am Acad Dermatol. 2016 Jan 14. pii: S0190-9622(15)02471.
    PubMed     Text format     Abstract available


  44. HWANG SJ, Carlos G, Wakade D, Byth K, et al
    Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
    J Am Acad Dermatol. 2016 Jan 12. pii: S0190-9622(15)02387.
    PubMed     Text format     Abstract available


  45. ELSTON DM, Stratman EJ, Miller SJ
    Skin biopsy: Biopsy issues in specific diseases.
    J Am Acad Dermatol. 2016;74:1-16.
    PubMed     Text format     Abstract available


    December 2015
  46. FUTAMURA M, Leshem YA, Thomas KS, Nankervis H, et al
    A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards.
    J Am Acad Dermatol. 2015 Dec 11. pii: S0190-9622(15)02284.
    PubMed     Text format     Abstract available


    November 2015
  47. DODIUK-GAD RP, Olteanu C, Jeschke MG, Cartotto R, et al
    Treatment of toxic epidermal necrolysis in North America.
    J Am Acad Dermatol. 2015;73:876-7.
    PubMed     Text format    


  48. SHI VY, Leo M, Hassoun L, Chahal DS, et al
    Role of sebaceous glands in inflammatory dermatoses.
    J Am Acad Dermatol. 2015;73:856-63.
    PubMed     Text format     Abstract available


  49. SZATKOWSKI J, Schwartz RA
    Acute generalized exanthematous pustulosis (AGEP): A review and update.
    J Am Acad Dermatol. 2015;73:843-8.
    PubMed     Text format     Abstract available


  50. RUBEN BS, Yu WY, Liu F, Truong SV, et al
    Generalized benign cutaneous reaction to cytarabine.
    J Am Acad Dermatol. 2015;73:821-8.
    PubMed     Text format     Abstract available


    October 2015
  51. SHARMA M, Bennett C, Carter B, Cohen SN, et al
    H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review.
    J Am Acad Dermatol. 2015;73:710-716.
    PubMed     Text format     Abstract available


    September 2015
  52. CASCELLA R, Strafella C, Germani C, Manzo L, et al
    FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation.
    J Am Acad Dermatol. 2015;73:528-9.
    PubMed     Text format    


  53. DELYON J, Ortonne N, Benayoun E, Moroch J, et al
    Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    J Am Acad Dermatol. 2015;73:484-90.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: